SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 52.51+2.7%Nov 14 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (2774)2/1/2001 10:29:47 PM
From: Mark Bong  Read Replies (1) of 52153
 
Miljenko, It is well known that the large Wall Street firms make their profits from trading, not from long term investing. Therefore, it is not always in their interests of some analysts to be honest, unless it suits their interests in maximizing their trading profits. We can beat them with long term investments, because we work to understand the industry, and we often invest in good companies with good potential. Being right 30% of the time is very rewarding. Wall Street, as well as foreign markets, have never functioned like that for the market makers. I feel that you are right. They are looking for a buying opportunity, and they have to buy in large quantities to make real money. There is also some truth that some of these companies may be overvalued, but some are very good investments if you have a long-term time horizon. Truth will only consistently emerge from some news sources and from folks like us, and of course, we are also wrong sometimes. Otherwise, the analyst comments will always have to be looked at skeptically. They may not always be wrong with their comments, but there are too many conflicts of interest that are forced upon analysts to listen and to believe them at face value. JMHO Best Wishes! Mark
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext